-ATPase (SERCA2) expression and activity, but sarcoplasmic reticulum Ca 2ϩ leak was unchanged. In the present study, we investigated whether SERCA2 overexpression in MI myocytes would restore contraction and [Ca 2ϩ ]i transients to normal. Compared with sham-operated hearts, 3-wk MI hearts exhibited significantly higher left ventricular end-diastolic and endsystolic volumes but lower fractional shortening and ejection fraction, as measured by M-mode echocardiography. Seventy-two hours after adenovirus-mediated gene transfer, SERCA2 overexpression in 3-wk MI myocytes did not affect Na ϩ -Ca 2ϩ exchanger expression but restored the depressed SERCA2 levels toward those measured in sham myocytes. In addition, the reduced sarcoplasmic reticulum Ca 2ϩ uptake in MI myocytes was improved to normal levels by SERCA2 overexpression. At extracellular Ca 2ϩ concentration of 5 mM, the subnormal contraction and [Ca 2ϩ ]i transient amplitudes in MI myocytes (compared with sham myocytes) were restored to normal by SERCA2 overexpression. However, at 0.6 mM extracellular Ca 2ϩ concentration, the supernormal contraction and [Ca 2ϩ ]i transient amplitudes in MI myocytes (compared with sham myocytes) were exacerbated by SERCA2 overexpression. We conclude that SERCA2 overexpression was only partially effective in ameliorating contraction and [Ca 2ϩ ]i transient abnormalities in our rat model of ischemic cardiomyopathy. We suggest that other Ca 2ϩ transport pathways, e.g., Na ϩ -Ca 2ϩ exchanger, may also play an important role in contractile and [Ca 2ϩ ]i homeostatic abnormalities in MI myocytes. primary cardiac myocyte culture; fura 2; excitation-contraction coupling; gene transfer CA 2ϩ TRANSPORT SYSTEMS IN sarcoplasmic reticulum (SR) play a major role in cardiac excitation-contraction coupling. During an action potential, Ca 2ϩ entry via L-type Ca 2ϩ channels triggers SR Ca 2ϩ release by the ryanodine receptor, resulting in increases in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and myofilament activation. During diastole, most of the myoplasmic Ca 2ϩ is resequestered in the SR by sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA2). The amount of Ca 2ϩ that has entered during systole is extruded by the Na ϩ -Ca 2ϩ exchanger (NCX1) and to a minor extent by sarcolemmal Ca 2ϩ -ATPase. It is the coordinated actions of L-type Ca 2ϩ channels, SERCA2, NCX1, and to a lesser extent, sarcolemmal Ca 2ϩ -ATPase that allow the myocyte to maintain beat-to-beat Ca 2ϩ balance.
In most animal models of heart failure as well as human heart failure, SR Ca 2ϩ uptake activities and SERCA2 expression were depressed (13, 15) . Focusing on the rat model of myocardial infarction (MI), Afzal and Dhalla (1) first showed depressed ATP-dependent Ca 2ϩ uptake in SR membrane fractions isolated from rat left ventricles (LV) at 4, 8, and 16 wk after MI. Specifically, maximal velocity of ATP-dependent Ca 2ϩ uptake by SR membranes was decreased, but affinity for Ca 2ϩ was unchanged. Follow-up studies suggested the reduction in maximal velocity of SR Ca 2ϩ uptake was due to decreases in SERCA2 mRNA and protein levels after an MI (27) . Using a fundamentally different approach, we reported SR Ca 2ϩ uptake activity, and SERCA2 protein levels were depressed in intact myocytes isolated from rat hearts 3 wk after MI (32) . In addition, SR Ca 2ϩ content in post-MI myocytes was significantly reduced when compared with sham-operated myocytes (35) . Decreased SR Ca 2ϩ content not only reduced the maximal amount of SR Ca 2ϩ available for release during a twitch but also lowered the gain (ratio of trigger Ca 2ϩ to Ca 2ϩ released from the SR) of SR Ca 2ϩ -release channels (24) . Decreased SR Ca 2ϩ content in heart failure may be due to reduced SR Ca 2ϩ uptake by SERCA2, enhanced Ca 2ϩ extrusion by NCX1, or increased SR Ca 2ϩ leak (3). The role of increased SR Ca 2ϩ leak in causing decreased SR Ca 2ϩ content in heart failure is at present controversial (3, 16, 17) . In rat hearts studied 3 wk post-MI, we did not find any changes in SR Ca 2ϩ leak compared with sham-operated hearts (32) . In addition, in this rat post-MI model, NCX1 activities were also reduced rather than increased (11, 35) . These findings, together with similar L-type Ca 2ϩ current densities between sham and post-MI myocytes (30) , suggest that reduced SR Ca 2ϩ content was most likely due to decreased SERCA2 amounts and activities in post-MI myocytes. An attractive hypothesis is that reduced SERCA2 levels and activities can account for decreased SR Ca 2ϩ content, resulting in abnormal [Ca 2ϩ ] i transient (5, 29) and contractile behavior (5, 31) in post-MI rat myocytes. Because it is possible to transiently upregulate SERCA2 in rat myocytes by adenovirus-mediated gene transfer (12) , the present study was undertaken to test the hypothesis that overexpression of SERCA2 in post-MI rat myocytes would restore contractile and [Ca 2ϩ ] i transient abnormalities toward normal.
METHODS
Animal preparation. To induce MI, the left main coronary artery of each anesthetized (ketamine 60 mg/kg ip; xylazine 2 mg/kg ip), intubated, and ventilated (air) male Sprague-Dawley rat (weight ϳ300 g) was ligated 3-5 mm distal to its origin from the ascending aorta (5, 23, 28 -33, 35, 36) . Sham operation was identical except that the coronary artery was not occluded. All surviving rats (ϳ30% perioperative mortality for MI and ϳ0% for sham) received rat chow and water ad libitum and were maintained on a 12:12-h light-dark cycle. Survivors of coronary artery ligation typically had 36 Ϯ 3% of myocardium infarcted as determined histologically (20) . In addition, despite no overt signs of congestive heart failure (edema, ascites) in MI rats, infarcted hearts perfused in vitro had 20% lower LV systolic pressure at 1 and 3 wk after infarction (5) . Three weeks after MI, after anesthetized with pentobarbital sodium (35 mg/kg body wt ip), hearts from sham-operated and MI rats were excised for myocyte isolation. Our previous studies indicate that myocyte maladaptations post-MI were well established by 3 wk (5, 29, 30 -32, 35) . The protocols for induction of MI and myocyte isolation were approved by the Institutional Animal Care and Use Committee.
Included in this study are a total of 10 sham-operated and 17 rats that had survived MI. For contraction studies, myocytes isolated from 7 sham and 13 MI rats were used. For [Ca 2ϩ ]i transient studies, myocytes isolated from three sham and four MI rats were used. For Western blots, myocyte homogenates from six sham and seven MI rat hearts were used. Echocardiographic studies were performed on the first five sham-operated and five MI rats.
Echocardiographic evaluation. Three weeks after sham or MI operation, rats were anesthetized with isoflurane (3-5%) and oxygen (95-97%) via facemask. The left hemithorax was shaved, and a prewarmed ultrasound transmission gel was applied to the precordium. Transthoracic echocardiography was performed using an Agilent Sonos 5500 M2424A Ultrasound System (Andover, MA) equipped with a 12-MHz transducer (model 15-6L). The heart was first imaged in the two-dimensional mode in the parasternal long-axis view identifying the mitral and aortic valves and the apex. Short axis views were recorded at the level of midpapillary muscles. M-mode images obtained at the midpapillary muscle level were used for measurement of wall thickness and chamber dimensions. LV internal dimension at end-diastole (LVIDD) and at end-systole (LVIDS), as well as anterior and posterior wall thicknesses, were measured from M-mode tracings. Fractional shortening was calculated as (LVIDD Ϫ LVIDS)/LVIDD. LV end-diastolic (LVEDV) and end-systolic volumes (LVESV) were calculated by the formulae 1.047 ϫ LVIDD 3 and 1.047 ϫ LVIDS 3 , respectively (21) . LV stroke volume was defined as LVEDV Ϫ LVESV, and ejection fraction was calculated as (LVEDV Ϫ LVESV)/LVEDV. LV mass was given by the formula LV mass ϭ 1.04[(anterior wall thickness ϩ LVIDD ϩ posterior wall thickness) 3 Ϫ (LVIDD) 3 ] (21). All measurements were averaged over three consecutive cardiac cycles. Data were analyzed offline using Access Point 2000 software (Freeland Systems LLC, Westfield, IN).
Construction of recombinant, replication-deficient adenovirus-expressing SERCA2. The basic protocol is described by He et al. (14) . Briefly, the coding sequence of rat heart SERCA2 (a generous gift from Dr. Jonathan Lytton at the University of Calgary) was released from pMT2 by sequential digestion with HindIII and SacI. The SERCA2 sequence (3,634 bp) was first subcloned into pSP73 vector (Promega, Madison, WI) using HindIII and SacI restriction sites and then released from pSP73 by digestion with HindIII and EcoRV. The released SERCA2 sequence was inserted into the shuttle vector pAdTrack-cytomegalovirus (CMV) with the same HindIII and EcoRV restriction sites on the shuttle vector. The SERCA2 sequence in pAdTrack-CMV was authenticated by sequencing. The shuttle vector plasmid was linearized with PmeI, mixed with supercoiled pAdEasy-1, and used to electroporate BJ5183 cells. The recombinants were identified by restriction endonuclease mapping (PacI). Once recombination was confirmed, supercoiled plasmid DNA was transformed into DH10B cells for large-scale amplification. The recombinant construct was linearized with PacI and used to transfect HEK293 cells. Recombinant adenovirus expressing both green fluorescent protein (GFP) and SERCA2 [each under a separate CMV promoter] (Adv-GFP-SERCA2) was harvested, purified by CsCl gradient centrifugation, and stored at Ϫ20°C in 5 mM Tris (pH 8.0), 50 mM NaCl, 0.05% bovine serum albumin, and 25% glycerol. The presence of SERCA2 coding sequence in recombinant adenovirus was confirmed by PCR with primers for the CMV promoter and the polyadenylation site of pAdTrack-CMV.
Myocyte isolation and culture. Cardiac myocytes were isolated from the septum and LV free wall of rat hearts by successive perfusion with collagenase and hyaluronidase (6) . Isolated myocytes were seeded on laminin-coated coverslips and cultured in modified serum-free medium 199 [extracellular Ca 2ϩ concentration ([Ca 2ϩ ]o) ϭ 1.8 mM], as described previously (22, 23, 25, 33, 34) . After 2 h, media were changed to remove nonadherent myocytes. The myocytes were incubated for an additional 3-4 h before initiation of pacing (1 Hz, 5-ms pulses of alternating polarity, field strength of 4 V/cm) using a custom-designed amplifier described previously (22, 34) . In later experiments, the C-Pacer system (Ionoptix, Milton, MA) was used to pace myocytes in culture (1 Hz, 4-ms pulses of alternating polarity, field strength of 5.3 V/cm). We found both stimulators maintained contractile function of myocytes in culture equally well. Culture media were changed daily. We have previously demonstrated that continuous pacing in culture preserved normal contractile function of rat myocytes for at least 72 h after isolation (22, 23) . In addition, we have also shown that MI myocytes maintained their contractile differences from sham myocytes even after 2-3 days of continuous pacing culture (23, 33) .
Adenoviral infection of cardiac myocytes. Two hours after isolation, myocytes seeded in four-well trays (Nuclone) were infected with either Adv-GFP-SERCA2 or adenovirus-expressing GFP alone (Adv-GFP) at a multiplicity of infection of two to five for 3-4 h. Media were then changed, and myocytes were studied after 72 h in continuous pacing culture. Over 95% of myocytes fluoresced green (excitation 478 nm, emission 535 nm) within 12-18 h, indicating successful adenoviral infection and GFP expression. We have previously shown that adenoviral infection did not affect contractility in sham and MI myocytes (23, 33) . For brevity, sham myocytes infected with Adv-GFP are referred to as sham-GFP myocytes, and MI myocytes infected with Adv-GFP and Adv-GFP-SERCA2 are referred to as MI-GFP and MI-SERCA2 myocytes, respectively.
Myocyte shortening measurements. Cell contraction was measured in myocytes incubated in HEPES-buffered (20 mM, pH 7.4) medium 199 (37°C), containing either 0.6, 1.8, or 5.0 mM [Ca 2ϩ ]o, by using a charged-couple device video camera and edge-detection software (Ionoptix) as described previously (22, 23, 25, 31, 33, 34) . For calibration of pixels vs. micrometer, a high-resolution test target (model 22-8635, Ealing Electro-Optics; Natick, MA) was used.
[Ca 2ϩ ]i transient measurements. Myocytes were exposed to 0.67 M of fura 2-AM for 15 min at 37°C. Fura 2 epifluorescence (excitation 360 and 380 Ϯ 10 nm bandpass; emission 510 Ϯ 18 nm bandpass) from paced myocytes (1 Hz, 37°C) was measured with our quantitative fluorescence microscopy system described previously (22, 25, 28, (32) (33) (34) using an Olympus DApo Ultraviolet ϫ40/1.30 numerical aperature oil objective. Background and cellular autofluorescence measured in sham-GFP and MI-GFP myocytes not loaded with fura 2 accounted for Ͻ10% of the fura 2 signal (34). Intracellular fura 2 fluorescence was calibrated daily for each batch of myocytes, as previously described (7) . [Ca 2ϩ ]i transient data derived from fura 2 signals were analyzed with custom-written software (Ionoptix) (22, 25, 28, 29, (32) (33) (34) .
SERCA2, NCX1, and calsequestrin immunoblotting. Three days after adenovirus infection, cultured myocytes were rinsed three times with ice-cold phosphate buffered saline and then scraped into ice-cold lysis buffer as described previously (22, 23, 25, 33, 34) . Cell lysates were snap-frozen with dry ice/ethanol and stored at Ϫ80°C. Myocyte lysates (50 g) in SDS sample buffer were subjected to 7.5% polyacrylamide gel electrophoresis under either nonreducing (10 mM N-ethylmaleimide for NCX1) or reducing (5% ␤-mercaptoethanol for SERCA2 and calsequestrin) conditions. Fractionated proteins were transferred onto ImmunBlot polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). NCX1 was detected with a mouse monoclonal antibody (1:1,000 dilution, R3F1, Swant; Bellinzona, Switzerland). SERCA2 was detected with another monoclonal antibody (1:2,500, MA3-919, Affinity Bioreagents; Golden, CO). Sheep antimouse antibody (1:2,000, Amersham; Piscataway, NJ) was used as the secondary antibody in both cases. To detect calsequestrin, a rabbit anti-calsequestrin antibody (1:5,000, Swant) and donkey anti-rabbit IgG (1:5,000, Amersham) were used. Immunoreactive proteins were detected with enhanced chemiluminescence-Western blotting system. Densitometric analysis was performed on a personal computer using the public domain National Institutes of Health Image Program (http://rsb.info.nih.gov/nih-image/).
Statistics. All results are expressed as means Ϯ SE. In experiments in which maximal contraction amplitudes and [Ca 2ϩ ]i transient dynamics were measured as a function of group (sham-GFP vs. MI-GFP vs. MI-SERCA2) and [Ca 2ϩ ]o, two-way ANOVA was performed to determine significances of differences. A linear model-fitted standard least squares analysis (JMP version 4.0.5, SAS Institutes; Cary, NC) was used. Significance of differences among the means of proteins (NCX1 and SERCA2) in the three experimental groups was determined by one-way ANOVA. A priori comparisons of means of any two groups were then performed by using F tests as tests of significance. Echocardiographic indexes of cardiac function in sham and MI rats were compared by Student's t-tests. In all analyses, P Յ 0.05 was taken to be statistically significant.
RESULTS
Effects of MI on in vivo cardiac performance. Three weeks after MI, there were no differences in body weight between sham and MI rats, although heart rate was significantly lower in MI rats (Table 1) . Both LVIDD and LVIDS were significantly elevated in MI hearts, whereas fractional shortening was significantly reduced. MI affected neither anterior wall thickness nor posterior wall thickness. Both LVEDV and LVESV were significantly elevated in MI hearts, and ejection fraction was significantly lower. LV stroke volumes were similar between sham and MI hearts, as were cardiac outputs (sham 170 Ϯ 12 ml/min; MI 152 Ϯ 11 ml/min; P Ͻ 0.30) and cardiac indexes (sham 460 Ϯ 36 ml⅐kg Ϫ1 ⅐min
Ϫ1
; MI 411 Ϯ 30 ml⅐kg Ϫ1 ⅐min Ϫ1 ; P Ͻ 0.33). LV mass was similar between sham and MI rats.
Effects of MI and Adv-GFP-SERCA2 infection on NCX1 and SERCA2 levels. In agreement with our laboratory's previous studies, which showed reduction in SERCA2 protein levels in 3-wk MI rat myocytes (32), SERCA2 levels were significantly lower in MI-GFP myocytes compared with sham-GFP myocytes ( Fig. 1; Table 2 ). As expected, adenovirus-mediated SERCA2 overexpression restored the depressed SERCA2 levels in MI-GFP myocytes to normal. Although NCX1 abundance tended to be lower in MI-GFP myocytes, statistically there were no significant differences in NCX1 protein levels among the three experimental groups.
Effects of MI and SERCA2 overexpression on contractile function in cultured myocytes. We have previously characterized contractile abnormalities in freshly isolated myocytes from 3-wk MI rat hearts (5, 31, 33) . To reiterate, compared with sham myocytes, steady-state contraction amplitudes of MI myocytes were higher at 0.6, similar at 1.8, and lower at 5.0 mM [Ca 2ϩ ] o . We have also shown that adenoviral infection Composite results are presented in Table 2 . Numbers on left refer to apparent molecular mass in kDa. Sham-GFP, myocytes isolated from sham-operated hearts and infected with adenovirus expressing green fluorescent protein (GFP) (Adv-GFP) for 72 h; MI-GFP and MI-SERCA2, myocytes isolated from 3-wk MI rat hearts and infected for 72 h with Adv-GFP and adenovirus expressing GFP and SERCA2 (Adv-GFP-SERCA2), respectively. ] o compared with sham-GFP myocytes ( Fig. 3; Table 4 ). SERCA2 overexpression in MI myocytes increased [Ca 2ϩ ] i transient amplitudes to levels that were even higher than those observed in sham-GFP myocytes (Table 4) . In all three groups Table 3 . 
DISCUSSION
Previous invasive hemodynamic studies on our rat MI model with moderate-size infarct (36 Ϯ 3%) indicated that resting heart rate, cardiac output, and arteriovenous oxygen difference were similar between sham and MI rats (20) . The normal cardiac output in MI rats was achieved at the expense of significantly elevated LVEDP, indicating a compensated heart failure state (20) . Depressed cardiac function post-MI was clearly demonstrated when hearts were excised and perfused in vitro. Under conditions of constant left atrial filling pressure, afterload, and pacing frequency, MI hearts developed significantly lower LV systolic pressure and rate of rise of pressure (dP/dt) (5) . In the present experiments using noninvasive echocardiography, we confirmed that our 3-wk rat MI model represented a state of compensated heart failure in that relatively normal cardiac output was maintained at higher LVEDV and LVESV. Contractility, as measured by fractional shortening or ejection fraction, was depressed in MI hearts. There was no significant myocardial hypertrophy, in agreement with other studies that employed a similar rat MI model (4, 19) . Lack of increase in LV mass post-MI is also consistent with the mild (ϳ10%) increase in cell length but no change in cell width in myocytes isolated from MI rat hearts (5) .
There are many factors that account for compromised cardiac function post-MI: loss of viable myocardium, altered chamber geometry, mismatched capillary supply, interstitial fibrosis, and myocyte maladaptations. At the cellular level, known excitation-contraction coupling abnormalities post-MI include prolongation of action potential (36) , no change in L-type Ca 2ϩ current density (30), decreased Na ϩ -Ca 2ϩ exchange activity (11, 35) , decreased SR Ca 2ϩ uptake activity and SERCA2 levels (13, 15, 32) , reduced SR Ca 2ϩ content (35) , no alterations in SR Ca 2ϩ leak rate (16, 32) , shift of myosin heavy chain isoenzyme distribution from fast to slow forms, defective ␤-adrenergic receptor coupling (29) , and altered [Ca 2ϩ ] i transients (5, 29) and contractile behavior (5, 31) . Focusing on SR Ca 2ϩ regulatory systems, virtually all models Values are means Ϯ SE. Numbers in parentheses are pooled numbers of myocytes from 3 sham and 4 MI hearts. All myocytes were infected with adenovirus expressing either GFP or both GFP and rat heart SERCA2. Table 4. of heart failure demonstrated decreased SERCA2 protein levels and SR Ca 2ϩ uptake activities (13, 15) . This observation, coupled with the recent finding that adenovirus-mediated SERCA2 transfer in neonatal rat myocytes resulted in larger [Ca 2ϩ ] i transients and increased myocyte shortening (12) , suggests that SERCA2 overexpression may be a rational therapeutic strategy in ischemic cardiomyopathy.
The signature contractile phenotype exhibited by our rat myocytes studied 3-9 wk after MI is that, when compared with sham myocytes, contraction amplitudes were higher at 0.6 mM, not different at 1.8 mM, but lower at 5 mM [Ca 2ϩ ] o (23, 31, 33) . This reduced dynamic range of inotropic response to increasing [Ca 2ϩ ] o post-MI was still manifest in myocytes that had been subjected to 72 h of continued pacing culture and adenovirus infection. SERCA2 overexpression in MI myocytes resulted in increased contraction amplitudes at all three [Ca 2ϩ ] o to levels that even surpassed those measured in sham myocytes. In particular, SERCA2 overexpression failed to correct the "supernormal" contraction amplitude at 0. ] o levels in the present study) may not be evident. In a rat model of heart failure induced by aortic banding, SERCA2 overexpression was demonstrated to result in improvements in contractility, myocardial energetics, and animal survival (10) . Heart failure by aortic banding was likely due to pressureoverload and the pathogenetic mechanisms of heart failure from pressure overload are likely different than those in chronic ischemic cardiomyopathy. A more recent model of transient ischemia (30 min) followed by reperfusion in the rat also benefited by prior SERCA2 overexpression (9) . Specifically, decreased regional cardiac wall motion, reduced maximal rate of rise of LV pressure and relaxation, increased frequency of ventricular arrhythmias, and infarct size observed in ischemia/reperfusion rats were all improved by transient overexpression of SERCA2 before the onset of ischemia/ reperfusion injury. By contrast, our present study utilized a chronic ischemic model in which SERCA2 gene transfer occurred weeks after the initial ischemic insult, and thus the results of the two studies are not directly comparable. In transgenic mice overexpressing SERCA2, mortality at 24 h after surgically induced MI was unacceptably high (71%) compared with wild-type mice (35%) despite similar infarct sizes, perhaps due to higher frequency of ventricular arrhythmias (4). Disappointingly, despite transient (up to 1 mo) improvement in systolic and diastolic function in the noninfarcted LV inferior wall of transgenic hearts, global LV function (ejection fraction, isovolumic relaxation time) measured at 1-wk, 1-mo, and 3-mo intervals was not different between wild-type and transgenic mice overexpressing SERCA2 that had survived surgically induced MI (4). It should be noted that, although adenovirus-mediated SERCA2 transfer resulted in two-(10) to fourfold (Table 2 ) increases in SERCA2 protein levels, SERCA2 expression was only increased by 37% in transgenic mice (4) . This small increase in SERCA2 levels in transgenic hearts may account for the relatively modest effects on LV contractility post-MI. In any event, the results of published studies suggest that, whereas SERCA2 overexpression may indeed be beneficial in some models of heart failure (8 -10), it may not entirely ameliorate cardiac dysfunction in chronic ischemic cardiomyopathic models in rats (present study) and mice (4) . Indeed, caution should be exercised in recommending SERCA2 gene therapy for ischemic heart disease.
Of the major Ca 2ϩ transport systems in the cardiac myocyte, arguably SERCA2 and NCX1 are quantitatively the most important. We have previously suggested that depressed NCX1 activity in post-MI rat myocytes accounted for much of the contractile and [Ca 2ϩ ] i transient abnormalities (23, 25, 33 ] o , by NCX1 overexpression (23, 33) . Furthermore, the beneficial effects of high-intensity sprint training on [Ca 2ϩ ] i homeostasis (28) and contractility (23) in post-MI myocytes, part of which was mediated by restoring the depressed NCX1 activity, was totally abrogated by exposure to NCX1 antisense (23) . The results of the present study demonstrate that SERCA2 overexpression in post-MI rat myocytes did not totally correct [Ca 2ϩ ] i transient and contractile abnormalities and support our hypothesis that decreased NCX1 activity, rather than reduced SERCA2 or its activity, played a more important role in contractile abnormalities in our post-MI rat model. In this context, it is interesting to note that, 5 wk post-MI, transgenic mice overexpressing NCX1 maintained higher LV systolic pressure and maximal dP/dt lower LV end-diastolic pressure than wild-type mice, despite similar infarct sizes (18) . In addition, there were no significant ventricular arrhythmias in both wild-type and NCX1-overexpressing mice when examined 2 days post-MI (18) .
We have previously demonstrated that overexpression of NCX1 did not affect SERCA2 expression in post-MI rat myocytes (23) . In the present study, SERCA2 overexpression did not affect NCX1 expression in MI myocytes. This observation suggests that the effects of SERCA2 overexpression on contractility and [Ca 2ϩ ] i transients in MI myocytes was unlikely to be mediated by changes in NCX1 levels.
There are limitations to the study. The first is that echocardiographic evaluation was not performed on all of the experimental rats used in this study. In addition, post-MI hearts had significantly lower heart rates compared with sham-operated hearts. These slower heart rates found in the MI rats may potentially lead to a longer diastolic time interval that could be contributing to the greater LVEDV found in these animals. The second limitation is that we did not measure levels of phospholamban, which could affect SERCA2 activity. We note, however, that phospholamban mRNA levels were unchanged in a tachycardia-induced heart failure model in the dog (13) . In addition, phospholamban protein levels were similar in failing and nonfailing human myocardium (13) and between sham and MI rat myocytes (28) . We also note that adenoviral-mediated SERCA2 transfer in rat cardiac myocytes did not affect phospholamban expression (12) . It is thus reasonable to assume that, in the present study, the effect on contractility and [Ca 2ϩ ] i homeostasis were due to SERCA2 overexpression rather than secondary changes in phospholamban levels. A third limitation is that, in this study, we focused on the role of SERCA2 on contraction abnormalities in post-MI rat myocytes and ignored the other important steps involved in excitation-contraction coupling that are altered in post-MI myocytes (11, 13, 15, 30, 35, 36) . The importance of alterations in these other pathways (e.g., prolonged action potential duration, shift in myosin heavy chain isoenzyme distribution, etc.) in causing contractile dysfunction in post-MI myocytes needs to be addressed in future studies.
In summary, we have established an in vitro myocyte culture model system in which phenotypic differences between sham and post-MI myocytes were maintained for at least 72 h after isolation. Overexpression of SERCA2 in post-MI myocytes by adenovirus-mediated gene transfer, although improving contractile dysfunction at high [ 
